Literature DB >> 25243382

Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients.

Yuki Ishibashi1, Shimpei Nakatani, Yoshinobu Onuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25243382     DOI： 10.4244/EIJY14M09_08

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  3 in total

1.  Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.

Authors:  J Elias; I M van Dongen; R P Kraak; R Y G Tijssen; B E P M Claessen; J G P Tijssen; R J de Winter; J J Piek; J J Wykrzykowska; J P S Henriques
Journal:  Neth Heart J       Date:  2017-07       Impact factor: 2.380

Review 2.  Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes.

Authors:  Vasileios F Panoulas; Ioannis Mastoris; Klio Konstantinou; Maurizio Tespili; Alfonso Ielasi
Journal:  Med Devices (Auckl)       Date:  2015-07-24

3.  Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus-Eluting Bioresorbable Vascular Scaffold.

Authors:  Robin P Kraak; Hans H de Boer; Joëlle Elias; Carmen A Ambarus; Allard C van der Wal; Robbert J de Winter; Joanna J Wykrzykowska
Journal:  J Am Heart Assoc       Date:  2015-11-09       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.